Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic NET”

154 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 154 results

Early research (Phase 1)WithdrawnNCT02831179
What this trial is testing

Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor

Who this might be right for
Functional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more
Vanderbilt-Ingram Cancer Center
Not applicableStudy completedNCT04753229
What this trial is testing

Ki67 Proliferation Index of Pancreatic Neuroendocrine Neoplasia

Who this might be right for
Neuroendocrine Tumors
Institut Paoli-Calmettes 50
Early research (Phase 1)Study completedNCT03879694
What this trial is testing

Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors

Who this might be right for
Lung Atypical Carcinoid TumorLung Typical Carcinoid TumorMetastatic Pancreatic Neuroendocrine Tumor
Roswell Park Cancer Institute 19
Not applicableStudy completedNCT06557408
What this trial is testing

Pancreatic Fistula After Minimally Invasive Enucleation

Who this might be right for
Pancreatic Tumor, BenignPancreatic Neuroendocrine TumorSolid Pseudopapillary Tumor of the Pancreas
Fudan University 173
Testing effectiveness (Phase 2)Study completedNCT02162446
What this trial is testing

68Ga-OPS202 Study for Diagnostic Imaging of GEP NET

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumors
Ipsen 12
Not applicableEnded earlyNCT00730483
What this trial is testing

Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorMetastatic Cancer
Yale University 13
Post-approval studies (Phase 4)UnknownNCT02759718
What this trial is testing

Clinical Effectiveness of Serum Chromogranin A Levels on Diagnostic of Pancreatic Neuroendocrine Tumors

Who this might be right for
Non Functioning Pancreatic Endocrine Tumor
Asan Medical Center 111
Testing effectiveness (Phase 2)Study completedNCT02955069
What this trial is testing

Study of Efficacy and Safety of PDR001 in Patients With Advanced or Metastatic, Well-differentiated, Non-functional Neuroendocrine Tumors of Pancreatic, Gastrointestinal (GI), or Thoracic Origin or Poorly-differentiated Gastroenteropancreatic Neuroendocrine Carcinoma (GEP-NEC)

Who this might be right for
Well-differentiated Non-functional NET of Thoracic OriginWell-differentiated Non-functional NET of Gastrointestinal OriginWell-differentiated Non-functional NET of Pancreatic Origin+1 more
Novartis Pharmaceuticals
Not applicableStudy completedNCT03791346
What this trial is testing

Pancreatectomy for NET: External Evaluation of WHO 2017 Grading System

Who this might be right for
Pancreatic Surgery
University Hospital, Montpellier 138
Not applicableWithdrawnNCT06554730
What this trial is testing

MSD Belzutifan PAS

Who this might be right for
Von Hippel Lindau Disease
Merck Sharp & Dohme LLC
Not applicableStudy completedNCT03967951
What this trial is testing

CT Radiomic Features of Pancreatic Neuroendocrine Neoplasms

Who this might be right for
Pancreatic Neuroendocrine Tumor
Francesco De Cobelli 70
Testing effectiveness (Phase 2)Study completedNCT00416767
What this trial is testing

Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery

Who this might be right for
Gastrointestinal Carcinoid TumorIslet Cell TumorNeoplastic Syndrome
Federation Francophone de Cancerologie Digestive 20
Not applicableLooking for participantsNCT05037461
What this trial is testing

Precision Radiotherapy Using MR-linac for Pancreatic Neuroendocrine Tumours in MEN1 Patients

Who this might be right for
Neuroendocrine Tumor of PancreasMultiple Endocrine Neoplasia Type 1
J.M. de Laat 20
Testing effectiveness (Phase 2)Ended earlyNCT00466856
What this trial is testing

Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors

Who this might be right for
Head and Neck CancerIslet Cell TumorMetastatic Cancer+1 more
Vanderbilt-Ingram Cancer Center 10
Testing effectiveness (Phase 2)Study completedNCT01396382
What this trial is testing

68Ga-DOTATATE PET Scan in Neuroendocrine Cancer

Who this might be right for
Neuroendocrine Carcinoma
Vanderbilt-Ingram Cancer Center 97
Not applicableLooking for participantsNCT07554560
What this trial is testing

Nutrition Intervention for Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Pancreatic Neuroendocrine Tumor (NET)
Children's Hospital of Philadelphia 18
Not applicableStudy completedNCT06080204
What this trial is testing

Real-world Study on Adjuvant Octreotide Therapy in pNETs

Who this might be right for
Pancreatic Neuroendocrine Tumor G2
Changhai Hospital 411
Early research (Phase 1)Ended earlyNCT00002947
What this trial is testing

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more
Yale University 35
Testing effectiveness (Phase 2)Study completedNCT01024387
What this trial is testing

AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorCarcinoid TumorPancreatic Neuroendocrine Tumor
Dana-Farber Cancer Institute 60
Not applicableNo Longer AvailableNCT01980732
What this trial is testing

68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors

Who this might be right for
Carcinoid TumorsIslet Cell (Pancreatic NET)Other Neuroendocrine Tumors
Andrei Iagaru
Load More Results
116